This latest installment examines the profitability of Ashland, Grande Ronde, Columbia Memorial, Good Shepherd, Mid-Columbia, Santiam, Silverton, Sky Lakes, McKenzie-Willamette and Willamette Valley hospitals.
The new marquee drug Sovaldi has been a boon for its manufacturer, provoking big concerns among coordinated care organizations. But competition should soon eliminate its monopoly and help the healthcare system pay for this promising new cure for a deadly disease.